Reply
Muscle Nerve
.
2018 May;57(5):E130-E131.
doi: 10.1002/mus.26089.
Epub 2018 Mar 1.
Authors
Donald B Sanders
1
,
Yadollah Harati
2
,
Vern C Juel
1
,
Jau-Shin Lou
3
,
Tessa Marburger
4
,
Robert M Pascuzzi
5
,
Amanda C Peltier
6
,
David P Richman
7
,
A Gordon Smith
8
Affiliations
1
Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
2
Department of Neurology, Baylor College of Medicine, Houston, Texas, USA.
3
Department of Neurology, University of North Dakota School of Medicine & Health Science, Fargo, North Dakota, USA.
4
Catholic Health Initiative St. Alexius Health - Williston Medical Center, Williston, North Dakota, USA.
5
Department of Neurology, Indiana University, Indianapolis, Indiana, USA.
6
Department of Neurology, Vanderbilt Medical Center, Nashville, Tennessee, USA.
7
Department of Neurology, Center for Neuroscience, University of California, Davis, Davis, California, USA.
8
Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
PMID:
29406616
DOI:
10.1002/mus.26089
No abstract available
Publication types
Letter
Comment
MeSH terms
Amifampridine*
Humans
Lambert-Eaton Myasthenic Syndrome*
Substances
Amifampridine